FrancophonIA/ELRC3.0 huggingface dataset:
English: Other side effects such as kidney failure, a decrease in the levels of uric acid in your blood, pulmonary hypertension, male infertility (which is reversible once treatment with this medicine is stopped), cutaneous lupus (characterized by rash/erythema on skin areas that are exposed to light), psoriasis (new or worsening) and DRESS may also occur with a not known frequency.
Estonian: Teadmata esinemissagedusega võivad esineda teised kõrvaltoimed nagu neerupuudulikkus, kusihappesisalduse langus veres, pulmonaarne hüpertensioon, meeste viljatus (pöörduv pärast ravi lõpetamist selle ravimiga), naha luupus (iseloomulik lööve/erüteem nahal, mis on päikesevalgusega kokkupuutes), psoriaas (esmane või süvenemine) ja DRESS.
English: The long half-life of leflunomide should be considered when contemplating administration of a live attenuated vaccine after stopping Leflunomide ratiopharm.
Estonian: Elusvaktsiinidega vaktsineerimise planeerimisel pärast ravi lõpetamist Leflunomide ratiopharm'iga, tuleb arvestada leflunomiidi pika poolväärtusajaga.
English: EU/1/10/654/003 30 film-coated tablets EU/1/10/654/004 100 film-coated tablets
Estonian: EU/1/10/654/003 30 õhukese polümeerikattega tabletti EU/1/10/654/004 100 õhukese polümeerikattega tabletti
English: You will normally take Leflunomide ratiopharm over long periods of time.
Estonian: Tavaliselt kestab ravi Leflunomide ratiopharmiga pikka aega.
English: EU/1/10/654/001 30 film-coated tablets EU/1/10/654/002 100 film-coated tablets
Estonian: EU/1/10/654/001 30 õhukese polümeerikattega tabletti EU/1/10/654/002 100 õhukese polümeerikattega tabletti
English: How to take Leflunomide ratiopharm
Estonian: Kuidas Leflunomide ratiopharm võtta
English: diarrhoea, nausea, vomiting, oral mucosal disorders (e.g., aphthous stomatitis, mouth ulceration), abdominal pain; colitis including microscopic colitis such as lymphocytic colitis, collagenous colitis
Estonian: diarröa, iiveldus, oksendamine, suu limaskesta kahjustus (nt aftoosne stomatiit, haavandid suus), kõhuvalu; koliit, sh mikroskoopiline koliit, nt lümfotsütaarne koliit ja kollageenkoliit
English: Tell your doctor immediately and stop taking Leflunomide ratiopharm: if you experience weakness, feel light-headed or dizzy or have difficulty breathing, as these may be signs of a serious allergic reaction, if you develop a skin rash or ulcers in your mouth, as these may indicate severe, sometimes life-threatening reactions (e.g. Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, Drug Reaction with Eosinophilia and Systemic Symptoms [DRESS]), see section 2.
Estonian: • kui teil tekib nahalööve või suuhaavandid, kuna see võib viidata tõsise, mõnikord eluohtliku reaktsiooni tekkele (nn Stevensi-Johnsoni sündroom, toksiline epidermise nekrolüüs, multiformne erüteem, eosinofiilia ja süsteemsete sümptomitega ravimireaktsioon (ingl DRESS)), vt lõik 2.
English: Teva Nederland B.V. Tel: +31 (0) 800 0228 400
Estonian: Tel: +31 (0)800 0228 400
English: • Hypersensitivity (especially previous Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme) to the active substance, to the principal active metabolite teriflunomide, to peanut or soya or to any of the excipients listed in section 6.1.
Estonian: • Ülitundlikkus toimeaine, peamise aktiivse metaboliidi, teriflunomiidi, või lõigus 6.1 loetletud mistahes abiainete suhtes (eriti varasem Stevensi-Johnsoni sündroom, toksiline epidermolüüs, multiformne erüteem).
English: It is not recommended to drink alcohol during treatment with Leflunomide ratiopharm.
Estonian: Ravi vältel Leflunomide ratiopharmiga ei ole soovitatav tarbida alkoholi.
English: • The Summary of Product Characteristics
Estonian: • mõnede maksatalitluse näitajate väärtuse suurenemine,
English: Sodium laurylsulfate Magnesium stearate
Estonian: Naatriumlaurüülsulfaat Magneesiumstearaat
English: Each tablet contains 10 mg of leflunomide.
Estonian: Iga tablett sisaldab 10 mg leflunomiidi.
English: Each tablet contains 20 mg of leflunomide.
Estonian: Iga tablett sisaldab 20 mg leflunomiidi.
English: The unbound fraction of A771726 is about 0.62%.
Estonian: Seondumata fraktsioon moodustab ligikaudu 0,62%.
English: Musculoskeletal and connective tissue disorders Common:
Estonian: Lihas-skeleti ja sidekoe häired
English: If ALT (SGPT) elevations of more than 2-fold the upper limit of normal persist or if ALT elevations of more than 3fold the upper limit of normal are present, leflunomide must be discontinued and wash-out procedures initiated.
Estonian: Ravi leflunomiidiga tuleb katkestada ning alustada puhastusprotseduuri juhul, kui ALAT (SGPT) aktiivsuse väärtused on püsivalt enam kui 2 korda üle normi ülemise piiri või kui ALAT aktiivsuse väärtused on enam kui 3 korda üle normi ülemise piiri.
English: ratiopharm GmbH
Estonian: MÜÜGILOA HOIDJA NIMI JA AADRESS ratiopharm GmbH
English: Reproductive system and breast disorders Not known:
Estonian: Reproduktiivse süsteemi ja rinnanäärme häired
English: Skin and subcutaneous tissue disorders Common:
Estonian: Naha ja nahaaluskoe kahjutused
English: Leflunomide ratiopharm is contraindicated in pregnancy (see section
Estonian: Raseduse ajal on Leflunomide ratiopharm vastunäidustatud (vt lõik 4.3).
English: One film-coated tablet contains 20 mg of leflunomide.
Estonian: Üks õhukese polümeerikattega tablett sisaldab 20 mg leflunomiidi.
English: How to store Leflunomide ratiopharm
Estonian: Kuidas Leflunomide ratiopharm säilitada
English: Falsely low levels of calcium can be detected.
Estonian: Analüüs võib näidata tegelikult madalamat kaltsiumisisaldust veres;
English: - if you are male and wish to father a child. As it can not be excluded that Leflunomide ratiopharm passes into semen, reliable contraception should be used during treatment with Leflunomide ratiopharm.
Estonian: Ei saa välistada Leflunomide ratiopharmi eritumist seemnevedelikku, ravi ajal Leflunomide ratiopharmiga tuleb kasutada tõhusat rasestumisvastast vahendit.
English: Leflunomide ratiopharm 20 mg tablets Leflunomide
Estonian: Leflunomide ratiopharm 20 mg tabletid
English: urticaria
Estonian: Koliit
English: Leflunomide ratiopharm 10 mg tablets Leflunomide
Estonian: Leflunomide ratiopharm 10 mg tabletid
English: • Patients with impairment of liver function,
Estonian: • kõhulahtisus,
English: Metabolism and nutrition disorders Common:
Estonian: Ainevahetus- ja toitumishäired
English: increased hair loss, eczema, rash (including maculopapular rash), pruritus, dry skin
Estonian: juuste suurenenud väljalangemine, ekseem, lööve (sh makulopapulaarne lööve),
English: Nervous system disorders Common:
Estonian: Närvisüsteemi häired
English: - sulfasalazine for inflammatory bowel disease or rheumatoid arthritis
Estonian: • sulfasalasiini põletikulise soolehaiguse või rematoidartriidi korral;
English: severe increase in blood pressure Respiratory, thoracic and mediastinal disorders Rare:
Estonian: Respiratoorsed, rindkere ja mediastiinumi häired
English: • Physician Leaflet
Estonian: • tisanidiini lihasrelaksandina;
English: renal failure
Estonian: Teadmata: neerupuudulikkus
English: One film-coated tablet contains 10 mg of leflunomide.
Estonian: • Üks õhukese polümeerikattega tablett sisaldab 10 mg leflunomiidi.
English: • The identified risk of synergistic hepato- or haematotoxicity associated with combination therapy with another Disease-Modifying Antirheumatic Drug (e.g. methotrexate)
Estonian: Teadaolev sünergistliku hepato- või hematotoksilisuse oht seoses kombinatsioonraviga teise haigust modifitseeriva antireumaatilise ravimiga (nt metotreksaat) Eksisteerib teratogeensuse oht ja seetõttu tuleb rasedust vältida kuni leflunomiidi sisaldus vereplasmas langeb kohase tasemeni.
English: Talk to your doctor, pharmacist or nurse before taking Leflunomide ratiopharm - if you have ever suffered from interstitial lung disease.
Estonian: Hoiatused ja ettevaatusabinõud Enne Leflunomide ratiopharmi võtmist pidage nõu oma arsti, apteekri või meditsiiniõega
English: Leflunomide ratiopharm 10 mg film-coated tablets Leflunomide
Estonian: Leflunomide ratiopharm 10 mg õhukese polümeerikattega tabletid Leflunomiid
English: Leflunomide ratiopharm 20 mg film-coated tablets Leflunomide
Estonian: Leflunomide ratiopharm 20 mg õhukese polümeerikattega tabletid Leflunomiid
English: Package leaflet: Information for the user Leflunomide ratiopharm 10 mg film-coated tablets
Estonian: RAVIMPREPARAADI NIMETUS Leflunomide ratiopharm 10 mg õhukese polümeerikattega tabletid
English: A. MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE
Estonian: A. RAVIMIPARTII KASUAMISEKS VABASTAMISE EEST VASTUTAVAD TOOTJAD B. HANKE- JA KASUTUSTINGIMUSED VÕI PIIRANGUD C. MUUD TINGIMUSED JA NÕUDED MÜÜGILOALE
English: Package leaflet: Information for the user Leflunomide ratiopharm 20 mg film-coated tablets
Estonian: RAVIMPREPARAADI NIMETUS Leflunomide ratiopharm 20 mg õhukese polümeerikattega tabletid
English: Alanine aminotransferase (ALT) or serum glutamopyruvate transferase (SGPT) and a complete blood cell count, including a differential white blood cell count and a platelet count, must be checked simultaneously and with the same frequency: before initiation of leflunomide, every two weeks during the first six months of treatment, and every 8 weeks thereafter (see section 4.4).
Estonian: Alaniinaminotransferaasi (ALAT) või seerumi glutamopüruvaattransferaasi (SGPT) ja hemogrammi, sh leukogrammi ja trombotsüütide arvu, tuleb kontrollida samal ajal ja sama sagedusega:
English: • Patients with severe immunodeficiency states, e.g. AIDS,
Estonian: • kui te põete haigust, mis pärsib teie immuunsüsteemi (nt AIDS),
English: • Hypersensitivity (especially previous Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme) to the active substance, to the principal active metabolite teriflunomide, to peanut or soya or to any of the excipients listed in section 6.1,
Estonian: liigeste valu, punased laigud nahal või villid - nn Stevensi-Johnsoni sündroom), maapähklite või soja või selle ravimi mis tahes koostisosade (loetletud lõigus 6) suhtes tekkinud allergiline reaktsioon,
English: Strength Pharmaceutic al form
Estonian: Tugevus Ravimvorm Loomaliigid Manustamisviis Pakend
English: United Kingdom Teva Uk Limited
Estonian: Ühendkuningriik Teva Uk Limited
English: United Kingdom Pronova Biopharma Norge As
Estonian: Ühendkuningriik Pronova Biopharma Norge As
English: S.P.A. Italiana Laboratori Bouty
Estonian: Italiana Laboratori Bouty
English: Fish Oil 0.5ml/Ml
Estonian: Kalaõli 0,5 ml/ml
English: United Kingdom Mercury Pharmaceuticals Ltd.
Estonian: Ühendkuningriik Mercury Pharmaceuticals Ltd.
English: 500mg Capsule
Estonian: 500 mg kapsel
English: Specific Composition For Epa And Dha Not Lower Than 85%.
Estonian: Erikoostisega oomega3-hapete (EPA ja DHA vähemalt 85%) etüülestrid 90.
English: Ratiopharm Gmbh Omega-3 Ratiopharm Omega-3-Acid Ethyl Esters 90 1000mg
Estonian: Ratiopharm Gmbh Omega-3 Ratiopharm Oomega-3-hapete etüülestrid 90, 1000 mg kapsel
English: 1000mg Capsule
Estonian: 1000 mg kapsel
English: United Kingdom Strides Arcolab International Limited
Estonian: Ühendkuningriik Strides Arcolab International Limited
English: Omega-3-Acid Ethyl Esters 90 With A Specific Composition For Epa And Dha Not Lower Than 85%.
Estonian: Omega 3 Alfasigma Erikoostisega oomega3-hapete (EPA ja DHA vähemalt 85%) etüülestrid 90.
English: Esters Of Unsaturated Fatty Acids 500mg Capsule
Estonian: Küllastumata rasvhapete estrid 500 mg kapsel
English: Ácidos Omega 3 Tarbis Docosahexaenoic Acid 380mg Capsule,
Estonian: Ácidos Omega 3 Tarbis Dokosaheksaeenhape 380 mg kapsel, eikosapentaeenhape
English: Fish Oil 1000mg Capsule
Estonian: Kalaõli 1000 mg kapsel
English: Triglycerides Medium Chain 1qs Capsule, Lecithin Soya 1qs Capsule, Omega-3-Acid Ethyl Esters 90 1000mg Capsule
Estonian: Keskpika ahelaga triglütseriidid 1 qs kapsel, sojaletsitiin 1 qs kapsel, oomega-3hapete etüülestrid 90, 1000 mg kapsel
English: Ácidos Omega 3 Aristo Omega-3-Acid Ethyl Esters 1000mg Capsule
Estonian: Ácidos Omega 3 Aristo Oomega-3-hapete etüülestrid 1000 mg kapsel
English: Omega-3 Fatty Acids 1000mg Capsule
Estonian: Oomega-3-rasvhapped 1000 mg kapsel
English: Esters Of Unsaturated Fatty Acids 1000mg Capsule
Estonian: Küllastumata rasvhapete estrid 1000 mg kapsel
English: Docosahexaenoic Acid 60mg Capsule, Eicosapentaenoic Acid 90mg Capsule
Estonian: Dokosaheksaeenhape 60 mg kapsel, eikosapentaeenhape 90 mg kapsel
English: Docosahexaenoic Acid 527mg/5ml, Eicosapentanoic Acid/Docosahexaenoic Acid 791mg/5ml
Estonian: Dokosaheksaeenhape 527 mg / 5 ml, eikosapentaanhape/dok osaheksaeenhape 791 mg / 5 ml
English: Docosahexaenoic Acid 115mg Capsule, Eicosapentanoic Acid/Docosahexaenoic Acid 170mg Capsule
Estonian: Dokosaheksaeenhape 115 mg kapsel, eikosapentaanhape/dok osaheksaeenhape 170 mg kapsel
English: Docosahexaenoic Acid 265mg/5ml, Eicosapentaenoic Acid 390mg/5ml
Estonian: Dokosaheksaanhape 265 mg / 5 ml, eikosapentaeenhape 390 mg / 5 ml
English: Docosahexaenoic Acid 120mg Capsule, Eicosapentaenoic Acid 180mg Capsule
Estonian: Dokosaheksaeenhape 120 mg kapsel, eikosapentaeenhape 180 mg kapsel
English: Acidos Omega 3 Stada Omega-3-Acid Ethyl Esters 90 1000mg
Estonian: Acidos Omega 3 Stada Oomega-3-hapete etüülestrid 90, 1000 mg kapsel
English: Docosahexaenoic Acid 115mg Capsule, Eicosapentaenoic Acid 170mg Capsule
Estonian: Dokosaheksaeenhape 115 mg kapsel, eikosapentaeenhape 170 mg kapsel
English: Docosahexaenoic Acid 527mg/5ml, Eicosapentaenoic Acid 791mg/5ml
Estonian: Dokosaheksaanhape 527 mg / 5 ml, eikosapentaeenhape 791 mg / 5 ml
English: Oral Emulsion
Estonian: Suukaudne emulsioon Suukaudne
English: Eicosapentaenoic Acid 791mg/5ml, Vitamin A 100 I.U.G
Estonian: Dokosaheksaanhape 527 mg / 5 ml, Dvitamiin 10 IU/g, eikosapentaeenhape 791 mg / 5 ml, Avitamiin 100 IU/g
English: Docosahexaenoic Acid 115mg Capsule, Vitamin D 1 I.U.G,
Estonian: Dokosaheksaeenhape 115 mg kapsel, Dvitamiin 1 IU/g, eikosapentaeenhape 170 mg kapsel, Avitamiin 1 IU/g
English: Pharmaceutical Form Route of administration
Estonian: Ravimvorm Manustamistee
English: The full EPAR for Pioglitazone Actavis can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Estonian: Euroopa avaliku hindamisaruande täistekst Pioglitazone Actavise kohta on ameti veebilehel: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: The medicine is available as tablets (15, 30 and 45 mg) and the recommended starting dose is 15 or 30 mg once a day.
Estonian: Pioglitazone Actavist turustatakse tablettidena (15, 30 ja 45 mg) ning soovituslik algannus on 15 või 30 mg üks kord ööpäevas.
English: What measures are being taken to ensure the safe and effective use of Pioglitazone Actavis?
Estonian: Mis meetmed võetakse, et tagada Pioglitazone Actavise ohutu ja efektiivne kasutamine?
English: Treatment with Pioglitazone Actavis should be reviewed after three to six months, and discontinued in patients who are not deriving sufficient benefit.
Estonian: Pioglitazone Actavise ravivastus tuleb kolme kuni kuue kuu möödudes läbi vaadata ning lõpetada ravi patsientidel, kes ei saa ravist piisavalt kasu.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Pioglitazone Actavis on 15 March 2012.
Estonian: Euroopa Komisjon andis Pioglitazone Actavise müügiloa, mis kehtib kogu Euroopa Liidus, 15. märtsil
English: The company that markets Pioglitazone Actavis will produce educational material for doctors prescribing the medicine, which will cover the possible risk of heart failure and bladder cancer with treatments that contain pioglitazone, the criteria for selecting patients and the need to review treatment regularly and stop treatment if patients are no longer benefiting.
Estonian: Pioglitazone Actavist turustav ettevõte koostab ravimit määravatele arstidele teabematerjalid, milles selgitatakse südamepuudulikkuse ja kusepõie vähi võimalikku riski pioglitasooni sisaldavate ravimite kasutamisel, patsientide valikukriteeriume ning vajadust ravi regulaarselt läbi vaadata ja lõpetada, kui see ei ole patsientidele enam kasulik.
English: Pioglitazone Actavis is used to treat type 2 diabetes in adults (aged 18 years or over), particularly those who are overweight.
Estonian: Pioglitazone Actavist kasutatakse eelkõige ülekaaluliste täiskasvanud (vähemalt 18-aastaste) patsientide II tüüpi diabeedi (suhkurtõve) raviks.
English: The active substance in Pioglitazone Actavis, pioglitazone, makes cells (fat, muscle and liver) more sensitive to insulin, which means that the body makes better use of the insulin it produces.
Estonian: Pioglitazone Actavise toimeaine pioglitasoon suurendab rakkude (rasva-, lihase- ja maksarakud) tundlikkust insuliini suhtes, mis tähendab, et organism kasutab paremini enda toodetavat insuliini.
English: The Committee recommended that Pioglitazone Actavis be approved for use in the EU.
Estonian: Komitee soovitas Pioglitazone Actavise kasutamise Euroopa Liidus heaks kiita.
English: This is a summary of the European public assessment report (EPAR) for Pioglitazone Actavis.
Estonian: See on ravimi Pioglitazone Actavis Euroopa avaliku hindamisaruande kokkuvõte.
English: What is Pioglitazone Actavis and what is it used for?
Estonian: Mis on Pioglitazone Actavis ja milleks seda kasutatakse?
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Pioglitazone Actavis have also been included in the summary of product characteristics and the package leaflet.
Estonian: Pioglitazone Actavise ohutu ja efektiivse kasutamise soovitused ja ettevaatusmeetmed tervishoiutöötajatele ja patsientidele on samuti lisatud ravimi omaduste kokkuvõttesse ja pakendi infolehele.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Pioglitazone Actavis has been shown to have comparable quality and to be bioequivalent to Actos.
Estonian: Inimravimite komitee järeldas, et vastavalt Euroopa Liidu nõuetele on tõendatud Pioglitazone Actavise võrreldav kvaliteet ja bioekvivalentsus ravimiga Actos.
English: Because Pioglitazone Actavis is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Estonian: Et Pioglitazone Actavis on geneeriline ravim ja võrdlusravimiga bioekvivalentne, peetakse tema kasulikkust ja riske samadeks mis võrdlusravimil.
English: This means that Pioglitazone Actavis is similar to a ‘reference medicine' already authorised in the European Union (EU) called Actos.
Estonian: See tähendab, et Pioglitazone Actavis on sarnane võrdlusravimiga Actos, millel juba on Euroopa Liidus müügiluba.
English: Pioglitazone Actavis
Estonian: Pioglitazone Actavis pioglitasoon
English: Because Pioglitazone Actavis is a generic medicine, studies in patients have been limited to tests to determine that it is bioequivalent to the reference medicine, Actos.
Estonian: Et Pioglitazone Actavis on geneeriline ravim, piirdusid patsiendiuuringud katsetega, milles näidati selle bioekvivalentsust võrdlusravimiga Actos.
English: Pioglitazone Actavis is a ‘generic medicine'.
Estonian: Pioglitazone Actavis on geneeriline ravim.
English: Other information about Pioglitazone Actavis
Estonian: Muu teave Pioglitazone Actavise kohta
English: For practical information about using Pioglitazone Actavis, patients should read the package leaflet or contact their doctor or pharmacist.
Estonian: Kui vajate Pioglitazone Actavise kasutamise praktilisi nõuandeid, lugege pakendi infolehte või pöörduge oma arsti või apteekri poole.
English: For more information about treatment with Pioglitazone Actavis, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Estonian: Kui vajate Pioglitazone Actavisega toimuva ravi kohta lisateavet, lugege palun pakendi infolehte (mis on samuti Euroopa avaliku hindamisaruande osa) või pöörduge oma arsti või apteekri poole.
English: It is not intended to provide practical advice on how to use Pioglitazone Actavis.
Estonian: Hindamisaruandes ei anta Pioglitazone Actavise kasutamise praktilisi nõuandeid.
English: Therefore, the CHMP's view was that, as for Actos, the benefit outweighs the identified risk.
Estonian: Seetõttu arvas inimravimite komitee, et nagu ka Actose korral, ületab Pioglitazone Actavise kasulikkus sellega kaasnevad riskid.
English: Why is Pioglitazone Actavis approved?
Estonian: Miks Pioglitazone Actavis heaks kiideti?
English: Pioglitazone Actavis contains the active substance pioglitazone.
Estonian: Pioglitazone Actavis sisaldab toimeainena pioglitasooni.
English: How is Pioglitazone Actavis used?
Estonian: Kuidas Pioglitazone Actavist kasutatakse?
English: How has Pioglitazone Actavis been studied?
Estonian: Kuidas Pioglitazone Actavist uuriti?
English: How does Pioglitazone Actavis work?
Estonian: Kuidas Pioglitazone Actavis toimib?
English: Pioglitazone Actavis can only be obtained with a prescription.
Estonian: Pioglitazone Actavis on retseptiravim.
English: What are the benefits and risks of Pioglitazone Actavis?
Estonian: Milles seisneb Pioglitazone Actavise kasulikkus ja mis riskid ravimiga kaasnevad?
English: Contains desiccant, do not eat.
Estonian: Sisaldab desikanti, mitte süüa.
English: (≥1/10,000 to <1/1,000).
Estonian: (≥1/10 000 kuni <1/1 000).
English: Try to take the tablet at the same time each day.
Estonian: Püüdke võtta tablett iga päev ühel ja samal kellaajal.
English: Some side effects can be serious and need immediate medical attention:
Estonian: Mõned kõrvaltoimed võivad olla rasked ning vajada kohest meditsiinilist sekkumist:
English: “Lot”, which is printed on the carton, refers to the batch number.
Estonian: „Lot“ mis on trükitud pakendile, viitab partii numbrile.
English: If you accidentally take too many tablets you may experience symptoms such as low blood pressure and rapid heartbeat.
Estonian: Kui te võtate kogemata liiga palju tablette, võivad teil esineda sellised sümptomid nagu madal vererõhk ja kiire südametöö.
English: This applies especially to the medicines listed below taken at the same time with Actelsar HCT:
Estonian: See käib eriti allpool loetletud ravimite kohta, kui neid kasutatakse samaaegselt Actelsar HCT:
English: Therefore the combination should be administered with caution, especially in the elderly.
Estonian: Seetõttu tuleb sellise kombinatsiooni kasutamisel olla ettevaatlik, eriti eakatel patsientidel.
English: For more detailed information see above under the heading “Cardiovascular prevention”.
Estonian: Täpsema teabe saamiseks vt eespool pealkirja all „Kardiovaskulaarne preventsioon“.
English: Actelsar HCT with food and alcohol
Estonian: Actelsar HCT koos toidu ja alkoholiga
English: Elderly Pharmacokinetics of telmisartan do not differ between the elderly and those younger than 65 years.
Estonian: Eakad Telmisartaani farmakokineetika ei erine alla 65-aastastel ja vanemaealistel inimestel.
English: About 60% of the oral dose is eliminated within 48 hours.
Estonian: Umbes 60% suukaudsest annusest elimineerub 48 tunni jooksul.
English: Contact your doctor, pharmacist, or your nearest hospital emergency department immediately.
Estonian: Pöörduge kohe oma arsti või apteekri poole või lähima haigla erakorralisse meditsiini osakonda.
English: Do not use this medicine after the expiry date which is stated on the carton, blister or bottle label after “EXP”.
Estonian: Ärge kasutage seda ravimit pärast kõlblikkusaega, mis on märgitud karbil, blistril või pudeli sildil pärast „EXP/Kõlblik kuni“.
English: Date of first authorisation: 13 March 2013 Date of latest renewal:
Estonian: Müügiloa esmase väljastamise kuupäev: 13 Märts 2013.
English: Epidemiological evidence regarding the risk of teratogenicity following exposure to ACE inhibitors during the first trimester of pregnancy has not been conclusive; however a small increase in risk cannot be excluded.
Estonian: Epidemioloogilised tõendid teratogeensuse riski kohta pärast AKE inhibiitorite kasutamist raseduse esimesel trimestril ei ole lõplikud; kuid siiski ei saa välistada riski vähest suurenemist.